MRI clues may point to a gene change in glioma
Original title: Beyond the visual T2-FLAIR mismatch: quantitative imaging markers of IDH mutation in Gliomas-A retrospective diagnostic accuracy study.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was a small look back at past scans of people, not a proven test for everyday care.
The short version
A brain MRI may give doctors an early clue about a glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary's gene change.
What was studied. Doctors looked back at 29 people with diffuse glioma: A glioma whose cells spread out into the brain around it instead of staying in one lump. That is why the edge on a scan is not a clean line. See the glossary. Each had a brain MRI before surgery. The team checked if scan patterns matched the IDH gene change: A small change in a tumor's IDH gene. It is the first thing your team looks at when naming an adult glioma, and it can affect which treatments are offered. Your pathology report says whether your tumor has it. See the glossary found in the tumor.
What they found. Nineteen tumors did not have the IDH gene change: A small change in a tumor's IDH gene. It is the first thing your team looks at when naming an adult glioma, and it can affect which treatments are offered. Your pathology report says whether your tumor has it. See the glossary change, and ten did. Tumors with the change looked brighter on the scans. One scan score spotted 90% of the changed tumors, and ruled out 89.5% of the others.
What this means, and what it doesn't
What it could mean: A scan may one day give doctors an early hint about tumor type. That hint could help guide talks about care while lab results are still pending.
What it doesn't mean: This does not mean a scan can replace a tissue test. It was a small look back at old scans, not a treatment study. The authors say one gene test was missing, so the results need checking in bigger groups. It is not a treatment, and it is not a cure.
Source: PubMed, September 11, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.